The median age of patients was 57 years (range: 1499 years) in our pharmacovigilance analysis and 60 years (range: 2777 years) for the cases of GLP-1 RAs-induced AP published in the case reports, which is in line with earlier observational studies on drug-induced AP (Zhou et al., 2022)
30-60 minutes before bed optimal
The most important pieces
Exploring the Mechanism of Action The efficacy of dihexa peptide lies in its ability to interact with particular brain receptors that regulate synaptic plasticity
Understanding your genetic predispositions in peptide metabolismalongside clinical labs (fasting glucose, insulin, HbA1c), BMI, comorbidities, and medication historycan support a more informed, personalized conversation with your provider about whether berberine, compounded GLP-1 agonists (semaglutide or tirzepatide), or a combination approach best supports your health goals and unique physiology